NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Supplying a Pharmacy for NASA Exploration Spaceflight: Challenges and Current UnderstandingIn order to maintain crew health and performance during long-duration spaceflight outside of low-Earth orbit, NASA and its international partners must be capable of providing a safe and effective pharmacy. Given few directed studies of pharmaceuticals in the space environment, it is difficult to characterize pharmaceutical effectiveness or stability during spaceflight; this in turn makes it challenging to select an appropriate formulary for exploration. Here we present the current state of literature regarding pharmaceutical stability, metabolism, and effectiveness during spaceflight. In particular, we have attempted to highlight the gaps in current knowledge and the difficulties in translating terrestrial-based drug studies to a meaningful interpretation of drug stability, safety, and effectiveness in space. We hope to identify high-yield opportunities for future research that might better define and mitigate pharmaceutical risk for exploration missions.
Document ID
20190034025
Acquisition Source
Johnson Space Center
Document Type
Accepted Manuscript (Version with final changes)
External Source(s)
Authors
Rebecca S Blue
(Mayo Clinic Scottsdale, Arizona, United States)
Tina M Bayuse
(KBR (United States) Houston, Texas, United States)
Vernie R Daniels
(KBR (United States) Houston, Texas, United States)
Virginia E Wotring
(Baylor College of Medicine Houston, Texas, United States)
Rahul Suresh
(The University of Texas Medical Branch at Galveston Galveston, Texas, United States)
Robert A Mulcahy
(Johnson Space Center Houston, Texas, United States)
Erik L Antonsen
(Baylor College of Medicine Houston, Texas, United States)
Date Acquired
December 19, 2019
Publication Date
June 13, 2019
Publication Information
Publication: npj Microgravity
Publisher: Nature Research
Volume: 5
Issue Publication Date: January 1, 2019
e-ISSN: 2373-8065
URL: https://www.nature.com/articles/s41526-019-0075-2
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-E-DAA-TN70241
E-ISSN: 2373-8065
Report Number: JSC-E-DAA-TN70241
Funding Number(s)
CONTRACT_GRANT: NNJ15HK11B
CONTRACT_GRANT: MOU-IPA
Distribution Limits
Public
Copyright
Public Use Permitted.
Technical Review
Single Expert
No Preview Available